NEW DRUGS
Participants working together on new drugs include:
|
William Plunkett, Ph.D., Working Group Chair
University of Texas MD Anderson Cancer Center |
|
Varsha Gandhi, Ph.D.
University of Texas MD Anderson Cancer Center |
|
Michael Hallek, M.D.
University of Cologne (Germany) |
|
Peng Huang, M.D., Ph.D.
University of Texas MD Anderson Cancer Center |
|
Deepa Sampath, Ph.D.
University of Texas MD Anderson Cancer Center |
|
Projects Funded
Development of New Drugs for CLL
William Plunkett, Ph.D.
Targeting anti-apoptotic proteins in CLL
Varsha Gandhi, Ph.D.
Preclinical testing of drug combinations for chronic lymphocytic leukemia (CLL)
Michael Hallek, M.D.
A Novel Therapeutic Strategy to Overcome CLL Drug Resistance Induced by Stromal Factors
Peng Huang, M.D., Ph.D.
Chromatin Modulation as a Therapeutic Strategy for CLL
Deepa Sampath, Ph.D.
|
